Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tissue microarrays: a current medical research tool.

Iqbal S Shergill1, N K Shergill, M Arya

  • 1Institute of Urology, University College London, UK. super_iqi@hotmail.com

Current Medical Research and Opinion
|May 14, 2004
PubMed
Summary

Tissue microarrays (TMAs) offer a rapid, cost-effective method for validating novel cancer markers. This high-throughput technique accelerates the analysis of numerous tissue specimens, aiding clinical practice.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Accelerated MRI-Guided Brachytherapy in Cervical Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same author

Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS Trial.

Radiology·2022
Same author

Clinical Applications of Substance P (Neurokinin-1 Receptor) Antagonist in Canine Medicine.

Archives of Razi Institute·2022
Same author

False Positive Multiparametric Magnetic Resonance Imaging Phenotypes in the Biopsy-naïve Prostate: Are They Distinct from Significant Cancer-associated Lesions? Lessons from PROMIS.

European urology·2020
Same author

Robotic-assisted partial nephrectomy (RAPN) and standardization of outcome reporting: a prospective, observational study on reaching the "Trifecta and Pentafecta".

Journal of robotic surgery·2020
Same author

Intraprostatic Cancer Recurrence following Radical Radiotherapy on Transperineal Template Mapping Biopsy: Implications for Focal Ablative Salvage Therapy.

The Journal of urology·2020

Area of Science:

  • Molecular biology
  • Pathology
  • Biotechnology

Background:

  • Novel molecular markers hold significant diagnostic, prognostic, and therapeutic potential, especially in oncology.
  • Traditional histopathological validation methods are time-consuming, labor-intensive, and costly, hindering clinical adoption of new markers.

Purpose of the Study:

  • To introduce and evaluate the tissue microarray (TMA) as a high-throughput technique for efficient marker validation.
  • To address the limitations of traditional histopathology in validating novel molecular markers for clinical use.

Main Methods:

  • Tissue microarray (TMA) construction by arraying tissue from up to 1000 histology blocks onto a single paraffin block.
  • Performing morphological and molecular investigations on arrayed tissue specimens.

Related Experiment Videos

Main Results:

  • TMA enables rapid and cost-effective validation of novel markers across multiple pathological specimens.
  • The technique significantly accelerates the processing of large tissue sample numbers while maintaining tissue quality and reliability.

Conclusions:

  • Tissue microarrays (TMAs) are established as a valuable tool for accelerating the validation of novel molecular markers.
  • TMAs facilitate the integration of new diagnostic and prognostic markers into clinical practice, offering ultimate clinical benefit.